{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T08:19:20Z","timestamp":1689927560310},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40360-017-0178-x","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T07:58:28Z","timestamp":1510819108000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetic study of single- and multiple-dosing with metolazone tablets in healthy Chinese population"],"prefix":"10.1186","volume":"18","author":[{"given":"Xueqing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"issue":"10","key":"178_CR1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/bmc.1583","volume":"25","author":"Y Jia","year":"2011","unstructured":"Jia Y, Zhang Y, Wang C, Wang Z, Liu Y, Wang J, Wen A. An improved LC-MS\/MS method for quantitative determination of metolazone in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr. 2011;25(10):1138\u201343.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"178_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2362.1985.tb00179.x","volume":"15","author":"C Marone","year":"1985","unstructured":"Marone C, Muggli F, Lahn W, Frey FJ. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur J Clin Investig. 1985;15(5):253\u20137.","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"178_CR3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cpt1974162322","volume":"16","author":"WJ Tilstone","year":"1974","unstructured":"Tilstone WJ, Dargie H, Dargie EN, Morgan HG, Kennedy AC. Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clin Pharmacol Ther. 1974;16(2):322\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"178_CR4","first-page":"12","volume":"32","author":"EB Ripley","year":"1994","unstructured":"Ripley EB, Gehr TW, Wallace H, Wade J, Kish C, Sica DA. The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone. Clin Pharmacol Ther. 1994;32(1):12\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"178_CR5","first-page":"116","volume":"29","author":"TW Gehr","year":"1991","unstructured":"Gehr TW, Sica DA, Brater DC, Wallace HJ, Davis J, Fakhry I. Metolazone pharmacokinetics and pharmacodynamics in renal transplantation. Clin Pharmacol Ther Toxicol. 1991;29(3):116\u201323.","journal-title":"Clin Pharmacol Ther Toxicol"},{"issue":"24","key":"178_CR6","first-page":"2446","volume":"20","author":"Y Qiao","year":"2011","unstructured":"Y Qiao, J Peng,YY Jia, ,MA Zhong-Ying, ,ZF Yang. Pharmacokinetics of metolazone tablet determined by LC-MS\/MS in healthy volunteers. Chinese Journal of New Drugs, 2011, 20 (24):2446-2449.","journal-title":"Chinese Journal of New Drugs"},{"issue":"2","key":"178_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-4347(93)E0427-R","volume":"653","author":"D Farthing","year":"1994","unstructured":"Farthing D, Sica DA, Fakhry I, Gehr TW. Novel high-performance liquid chromatographic method using solid-phase on-line elution for determination of metolazone in plasma and whole blood. Chromatogr B Biomed Appl. 1994;653(2):171\u20136.","journal-title":"Chromatogr B Biomed Appl"},{"key":"178_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0378-4347(00)82167-2","volume":"534","author":"D Farthing","year":"1990","unstructured":"Farthing D, Fakhry I, Gehr TW, Sica DA. Quantitation of metolazone in urine by high-performance liquid chromatography with fluorescence detection. Chromatographia. 1990;534:228\u201332.","journal-title":"Chromatographia"},{"issue":"1","key":"178_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchromb.2006.07.033","volume":"845","author":"G Wei","year":"2007","unstructured":"Wei G, Xiao S, Liu C. Determination of metolazone in human blood by liquid chromatography with electrospray ionization tandem mass spectrometry. Chromatogr B Analyt Technol Biomed Life Sci. 2007;845(1):169\u201373.","journal-title":"Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"178_CR10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jfda.2013.05.004","volume":"21","author":"C Yen-An","year":"2013","unstructured":"Yen-An C, Kuang-Yang H. Development of a LC-MS\/MS-based method for determining metolazone concentrations in human plasma: application to a pharmacokinetic study. J Food Drug Anal. 2013;21:154\u20139.","journal-title":"J Food Drug Anal"},{"issue":"2","key":"178_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-200645020-00003","volume":"45","author":"S Federico","year":"2006","unstructured":"Federico S, Carrano R, Capone D, Gentile A, Palmiero G. Pharmacokinetic interaction between levofloxacin and ciclosporin and tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation. Clin Pharmacokinet. 2006;45(2):169\u201375.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-017-0178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T07:58:30Z","timestamp":1510819110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-017-0178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s40360-017-0178-x","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"article-number":"73"}}